Abstract Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have demonstrated substantial weight reduction and cardiometabolic benefit in randomized trials; however, prospective implementation evidence from digital care models and female sex community populations remains limited.
Rachael Joy
As seen in:
MSN,
Nature,
USA Today,
Yahoo News,
U.S. News and World Report,
Chron,
Miami Herald,
Milwaukee Journal Sentinel,
Yahoo,
The Charlotte Observer
and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Rachael
Contact Rachael, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack